Bispecific Antibodies

This video explores one of the most exciting advancements in cancer therapy: bispecific antibodies. We'll break down how this powerful immunotherapy works as a "smart bridge," connecting your own immune cells directly to myeloma cells to launch a precise and powerful attack. Learn about this cutting-edge treatment and what it could mean for the future of myeloma care.

In this video, we cover:

• What Are Bispecific Antibodies? A simple guide to how these engineered proteins are designed with two unique arms to perform a special job.

• The "Bridge" Mechanism: See how one arm grabs a T-cell (your body's fighter cell) and the other grabs a myeloma cell, bringing them together for a targeted kill.

• Key Myeloma Targets: Learn about common targets on myeloma cells, like BCMA and GPRC5D, that these therapies are designed to find.

• The Patient Experience: An overview of how the treatment is given and what to expect, including the management of side effects like Cytokine Release Syndrome (CRS).

• Who is a Candidate? A look at where bispecific antibodies fit into the multiple myeloma treatment journey.